Arcutis to Present at Upcoming Investor Conferences
WESTLAKE VILLAGE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions, today announced that Arcutis management will participate in two upcoming investor conferences in September.
Details for the company’s participation are as follows:
Webcasts for these conferences may be accessed at the “Events & Presentations” section of the Company’s Investor website at https://investors.arcutis.com/events-and-presentations. Additionally, a replay of the webcasts will be available on the Arcutis website following the conferences.
Amanda Sheldon, Head of Corporate Communications
Eric McIntyre, Head of Investor Relations
Keynote: Cannabis Business and Technology 101
Keynote Presentation - Open to all Badge Holders
Digital Transformation Reengineering Process Production